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RECALLS
o https://www.fda.gov/Drugs/DrugSafety/DrugRecalls/default.htm
07/25/2017 Cantrell DrugCompany All unexpired sterile drug syringes and IV bags
Lack of sterility
assurance
Cantrell Drug
Company
07/21/2017 Super Panther7K Dietary Supplement
Unapproved new
drug
Ultra Shop
Supplement
07/13/2017
New of Kopi
Jantan
Tradisional
Natural Herbs Coffee Dietary Supplement
Unapproved new
drug, Undeclared
Milk Allergen
Bestherbs Coffee
LLC
07/11/2017 Andropharm Sten Z and M1 Alphas capsules Unapproved drug Andropharm
06/29/2017 Ultra-Sten, D-Zine Marketed as a dietary supplement
Presence of anabolic
steroids
Hardcore
Formulations
06/23/2017 Fagron SterileServices Succinylcholine Chloride 20mg/mL
Lack of Sterility
Assurance
Fagron Sterile
Services
06/22/2017 AdvancedPharma Potassium Phosphate and Succinylcholine Chloride
Lack of Sterility
Assurance
Advanced Pharma,
Inc. d/b/a Avella of
Houston
06/17/2017 Bristol-MyersSquibb Eliquis (apixaban) 5 mg Tablets Tablet Mix-Up Bristol-Myers Squibb
06/16/2017 Alvogen Clindamycin Injection USP Lack of sterilityassurance Alvogen
06/15/2017 Hospira
8.4% Sodium Bicarbonate Injection, USP, NeutTM (Sodium
Bicarbonate 4% additive solution), QUELICINTM
(Succinylcholine Chloride Injection, USP) and Potassium
Phosphates Injection, USP
Lack of Sterility
Assurance
Hospira Inc, A Pfizer
Company
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SHORTAGES
o https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm
 Drug Shortages: Additional News and Information
o https://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm349561.htm2016-
DRUG
 New Drug Product: Brineura
o http://www.empr.com/new-drug-product-brineura/slideshow/3946/?DCMP=EMC-
MPR_FirstLook_cp&cpn=Pharm&hmSubId=O7oGyhxXy0c1&hmEmail=zc9AEZF4x4rPbtLJAxJhmklDzcJVA8s10&NID=&c_id=&dl=0&spMailin
spM=17494355&spUserID=NDgyNTEwMTE5NjYS1&spJobID=1041535326&spReportId=MTA0MTUzNTMyNgS2
 Lupin intros generic Vigamox
o http://www.drugstorenews.com/article/lupin-intros-generic-vigamox?tp=i-H55-Q5U-3tl-60vGQ-1v-1qda-1c-z2d-60scI-
dsYq&utm_campaign=Daily&utm_source=Experian&utm_medium=email&cid=14989&mid=88878142
 Perrigo launches generic Axiron
o http://www.drugstorenews.com/article/perrigo-launches-generic-axiron?tp=i-H55-Q5U-3tl-60vGQ-1v-1qda-1c-z2i-60scI-
2IpHuE&utm_campaign=Daily&utm_source=Experian&utm_medium=email&cid=14989&mid=88878142
 Teva intros 2 new strengths of ADHD generic
o http://www.drugstorenews.com/article/teva-intros--new-strengths-adhd-generic?tp=i-H55-Q5U-3tl-60vGQ-1v-1qda-1c-z2k-60scI-
gPUYI&utm_campaign=Daily&utm_source=Experian&utm_medium=email&cid=14989&mid=88878142
 New Drug Product: Alunbrig
o http://www.empr.com/new-drug-product-alunbrig/slideshow/3976/?DCMP=EMC-
MPR_FirstLook_cp&cpn=Pharm&hmSubId=O7oGyhxXy0c1&hmEmail=zc9AEZF4x4rPbtLJAxJhmklDzcJVA8s10&NID=&c_id=&dl=0&spMailin
gID=17681256&spUserID=NDgyNTEwMTE5NjYS1&spJobID=1061378520&spReportId=MTA2MTM3ODUyMAS2
HOSPITAL
 Providers battle ‘fake’ healthcare news
o http://www.fiercehealthcare.com/patient-engagement/hospitals-battle-pervasive-issue-fake-health-
news?utm_medium=nl&utm_source=internal&mrkid=799132&mkt_tok=eyJpIjoiTm1VMk5EaG1OemRpTldNeCIsInQiOiI0TVhuQ0swcnQ3N
3ZvWnlcL3c1RWpyYUs2eWxuc1pZbXFlTm1DSzFuUXpWUWNza0VQZnR0ckowT3N3V3J3UmEzQmdycmVVa0RyVzB6aGJNOWQzMTZSaE5B
UGRDZExmNlpWaXhMY0YyWGE5OG9GQndFeFlYQ1lsM3FyWkZKUUF6VlIifQ%3D%3D
FDA
 New Antibiotic Baxdela Gets FDA Approval
o http://www.empr.com/news/delafloxacin-acute-bacterial-skin-structure-infections-abssi-mrsa-melinta/article/669709/?DCMP=EMC-
MPR_DailyDose_cp_20170620&cpn=Pharm&hmSubId=O7oGyhxXy0c1&hmEmail=zc9AEZF4x4rPbtLJAxJhmklDzcJVA8s10&NID=&c_id=&dl
=0&spMailingID=17494989&spUserID=NDgyNTEwMTE5NjYS1&spJobID=1041541928&spReportId=MTA0MTU0MTkyOAS2
 FDA Approves New ADHD Treatment Option
o http://www.consultant360.com/exclusives/fda-approves-new-adhd-treatment-option
 Endo to Pull Opana From the Market Following FDA Request
o http://www.pharmacytimes.com/product-news/endo-to-pull-opana-from-the-market-following-fda-
request?utm_term=%2526gt%3B%2526gt%3BClick%20Here%20to%20Read%20More&utm_campaign=PT%20Breaking%20eNews%207-6-
17&utm_content=email&utm_source=Act-On+Software&utm_medium=email&cm_mmc=Act-On%20Software-_-email-_-
Endo%20to%20Pull%20Opana%20From%20the%20Market%20Following%20FDA%20Request-_-
%2526gt%3B%2526gt%3BClick%20Here%20to%20Read%20More
 The 5 Latest FDA Drug Approvals
o http://drugtopics.modernmedicine.com/drug-topics/news/5-latest-fda-drug-approvals?GUID=EC22DC7A-8C9E-4231-BAFB-
C4E25C30003B&rememberme=1&ts=18072017
 FDA Approves New Option for SLE
o http://www.consultant360.com/exclusives/fda-approves-new-option-sle
 Opioid Pulled From Market Following FDA Request
o http://www.consultant360.com/exclusives/opioid-pulled-market-following-fda-request
 Report Calls on FDA to Adopt New Standard for Reviewing Opioids
o http://www.raps.org/Regulatory-Focus/News/2017/07/14/28087/Report-Calls-on-FDA-to-Adopt-New-Standard-for-Reviewing-
Opioids/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz%2DEmails
 FDA approves 2 more dosage strengths of Impax’s Focalin XR generic
o http://www.drugstorenews.com/article/fda-approves--more-dosage-strengths-impaxs-focalin-xr-generic?tp=i-H55-Q5U-3tl-60vGQ-1v-
1qda-1c-z2m-60scI-D5XYU&utm_campaign=Daily&utm_source=Experian&utm_medium=email&cid=14989&mid=88878142
 FDA Updates on Multistate Outbreak of Burkholderia cepacia Infections
o https://www.fda.gov/Drugs/DrugSafety/ucm511527.htm
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 MedWatch: The FDA Safety Information and Adverse Event Reporting Program
o https://www.fda.gov/Safety/MedWatch/default.htm
IMMUNIZATIONS
 Quiz: How Much Do You Know About Vaccination?
o http://drugtopics.modernmedicine.com/drug-topics/news/quiz-how-much-do-you-know-about-vaccination?GUID=EC22DC7A-8C9E-4231-
BAFB-C4E25C30003B&rememberme=1&ts=21062017
 Vaccination may be curbing ER visits for shingles
o http://www.reuters.com/article/us-health-shingles-er-visits-idUSKBN19I2S7
 Self-Administered 'Patch' Vaccines May Soon Become Reality
o http://www.empr.com/news/vaccine-patch-bandage-influenza-microneedle-self-administered/article/671928/?DCMP=EMC-
MPR_DailyDose_cp20170628&cpn=Pharm&hmSubId=O7oGyhxXy0c1&hmEmail=zc9AEZF4x4rPbtLJAxJhmklDzcJVA8s10&NID=&c_id=&dl=
0&spMailingID=17553487&spUserID=NDgyNTEwMTE5NjYS1&spJobID=1042186872&spReportId=MTA0MjE4Njg3MgS2
 Vaccine Information Statements (VISs)
o https://www.cdc.gov/vaccines/hcp/vis/index.html
 Announcement: Implementation of the Vaccine Adverse Event Reporting System 2.0 Reporting Form
o https://www.cdc.gov/mmwr/volumes/66/wr/mm6627a5.htm
 Parents, Get Your Teens Their Vaccines!
o https://consumer.healthday.com/kids-health-information-23/immunization-news-405/parents-get-your-teens-their-vaccines-724574.html
 High-Dose Flu Vaccine Improves Outcomes in Elderly Patients
o http://www.consultant360.com/exclusives/high-dose-flu-vaccine-improves-outcomes-elderly-patients
 Monitoring Pneumococcal Vaccine Administration in Older Adults
o http://www.managedhealthcareconnect.com/content/monitoring-pneumococcal-vaccine-administration-older-adults
 Vaccine Information Statements (VISs)
o https://www.cdc.gov/vaccines/hcp/vis/index.html
 2016-2017 Influenza Season: Availability of Antivirals
o https://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm534572.htm
INSURANCE
NEWS
 Pharmacist Expertise in Alzheimers May Be Overlooked
o http://www.managedhealthcareconnect.com/content/pharmacist-expertise-alzheimers-may-be-overlooked
 Demise of the Traditional Syringe and Rise of the Smart Syringe System
o http://www.consultant360.com/content/demise-traditional-syringe-and-rise-smart-syringe-system
 New CDC report: More than 100 million Americans have diabetes or prediabetes
o https://www.cdc.gov/media/releases/2017/p0718-diabetes-report.html
 Blood Sugar Swings Tied to Depression in Elderly With Type 2 Diabetes
o http://www.managedhealthcareconnect.com/content/blood-sugar-swings-tied-depression-elderly-type-2-diabetes
 Trump’s Executive Order on Drug Pricing Expected to be Pharma-Friendly
o http://www.managedhealthcareconnect.com/content/trump-s-executive-order-drug-pricing-expected-be-pharma-friendly
 Drug Prices: Could Taxing Sharp Increases Impact Costs?
o http://www.managedhealthcareconnect.com/article/drug-prices-could-taxing-sharp-increases-impact-costs
 Malaria drug protects fetal mice from Zika virus, NIH-funded study finds
o https://www.nih.gov/news-events/news-releases/malaria-drug-protects-fetal-mice-zika-virus-nih-funded-study-finds
 DEA clarifies guidance on forwarding unfilled e-prescribed controlled substances
o http://www.drugstorenews.com/article/dea-clarifies-guidance-forwarding-unfilled-e-prescribed-controlled-substances
 Opioid Reduction Strategies Could Improve Pain, Quality of Life
o http://www.consultant360.com/exclusives/opioid-reduction-strategies-could-improve-pain-quality-life
 "Serious" Risks Seen with Stopping Therapy After a Statin-Related Adverse Event
o http://www.jwatch.org/fw113131/2017/07/25/serious-risks-seen-with-stopping-therapy-after-
statin?query=pfwTOC&jwd=000020097761&jspc
 Extended Use Dates Provided by Pfizer to Assist with Emergency Syringe Shortages
o https://www.fda.gov/Drugs/DrugSafety/DrugShortages/ucm563360.htm
